Skandinaviska Enskilda Banken (SEB)
XENE icon

Skandinaviska Enskilda Banken (SEB)’s Xenon Pharmaceuticals XENE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,457
Closed -$1.49M – 897
2025
Q2 		$1.49M Hold
47,457
– – 0.01% 615
2025
Q1 		$1.59M Buy
47,457
+7,081
+18% +$269K 0.01% 599
2024
Q4 		$1.56M Hold
40,376
– – 0.01% 610
2024
Q3 		$1.59M Hold
40,376
– – 0.01% 623
2024
Q2 		$1.57M Buy
+40,376
New +$1.61M 0.01% 595

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return